ARG1 and neoplasm: An alternative approach has been proposed by Badeux et al., who showed that a stable ARG1 enzyme, pegzilarginase, administered systemically, can starve tumors of exogenous arginine and improve anti-tumor immunity, presumably through M1 polarization [58].